Biosfer Teslab Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Biosfer Teslab General Information

Description

Developer of in-vitro diagnostic tests intended to provide analytical services so that disorders in lipid metabolism and associated cardiovascular risk can be studied, diagnosed, and treated. The company's product is an advanced lipoprotein test that calculates the size and concentration of the particles that transport LDL cholesterol and measures levels of harmful lipoproteins in the blood, enabling healthcare professionals to assess cardiovascular risk in high-risk patients.

Contact Information

Website
www.biosferteslab.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Placa de Prim, 10
  • 2N 6a
  • 43201 Reus
  • Spain
+34 676
Primary Industry
Clinics/Outpatient Services
Other Industries
Laboratory Services (Healthcare)
Diagnostic Equipment
Corporate Office
  • Placa de Prim, 10
  • 2N 6a
  • 43201 Reus
  • Spain
+34 676

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosfer Teslab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 16-Oct-2023 Completed Generating Revenue
3. Accelerator/Incubator 23-Oct-2015 Completed Startup
2. Corporate 17-Sep-2014 Completed Startup
1. University Spin-Out 01-Dec-2013 Completed Startup
To view Biosfer Teslab’s complete valuation and funding history, request access »

Biosfer Teslab Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Biosfer Teslab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4592680-A1 Prognostic biomarkers for detection of colorectal cancer Inactive 24-Jan-2024
WO-2025157843-A1 Prognostic biomarkers for detection of colorectal cancer Pending 24-Jan-2024

Biosfer Teslab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosfer Teslab Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Rovira i Virgili University University
To view Biosfer Teslab’s complete investors history, request access »

Ready to get started?

Request a free trial

Biosfer Teslab FAQs

  • When was Biosfer Teslab founded?

    Biosfer Teslab was founded in 2013.

  • Where is Biosfer Teslab headquartered?

    Biosfer Teslab is headquartered in Reus, Spain.

  • What is the size of Biosfer Teslab?

    Biosfer Teslab has 8 total employees.

  • What industry is Biosfer Teslab in?

    Biosfer Teslab’s primary industry is Clinics/Outpatient Services.

  • Is Biosfer Teslab a private or public company?

    Biosfer Teslab is a Private company.

  • What is Biosfer Teslab’s current revenue?

    The current revenue for Biosfer Teslab is .

  • Who are Biosfer Teslab’s investors?

    Rovira i Virgili University has invested in Biosfer Teslab.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process